BioSpace News Archive

Today Accellix, the Cell Therapy QC company, announced a Series D financing round of $9.5 million led by bioMérieux, a world leader in the field of in vitro diagnostics for over 55 years. All existing major investors participated in this raise and have also agreed to convert their pre-existing convertible note in the amount of $8.5 million, bringing the company’s total funding in this round to $18 millio

Two leading hospital industry solutions veterans, Allen Technologies and Strategic Healthcare Connections LLC, announced today a new business partnership to help hospitals improve patient engagement, patient outcomes and operational efficiencies.

The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, in collaboration with Morgan Stanley GIFT Cures, announced 12 award winners in the COVID-19 Rapid Response Initiative.

X-Chem, Inc., the leader in DNA-encoded small molecule library screening, and ZebiAI Therapeutics, a drug discovery company unlocking new disease targets, today announced the publication of a large prospective study to evaluate the power of machine learning (ML) to accelerate and improve the drug discovery process

Cerecor Inc. (Nasdaq: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and orphan diseases, announced today the closing of the previously announced underwritten offering of 15,180,000 shares of its common stock (inclusive of 1,980,000 shares that were sold pursuant to the underwriter’s full exercise of its option to purchase additional shares of Cerecor’s commo

Today Mednet, a healthcare technology company, announced a new software release of its eClinical platform, iMednet.

The Biotechnology Innovation Organization (BIO) today released its ninth biennial report, “ The Bioscience Economy: Propelling Life-Saving Treatments, Supporting State & Local Communities ,” which highlights Michigan as a top state for the biosciences. The report studies the state of the U.S. bioscience industry and its associated inno

Approximately 7.5 million people in the U.S.1 have psoriasis, a chronic inflammatory disease that mostly affects the skin and joints but could also affect the nails.

As medical data increasingly highlights the serious impact of COVID-19 on children’s health, the National Capital Consortium for Pediatric Device Innovation (NCC-PDI) announces a special pitch competition focused on COVID-19-related pediatric medical devices that support home health monitoring and telehealth, and improve sustainability,

Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that, due to public health and safety concerns related to the outbreak of the novel coronavirus (“COVID-19"), and to support the health and well-being of its stockholders, employees and oth